COVID vaccine
Industries

Life Sciences Covid-19 Perspectives

CRA’s Life Sciences consultants have authored a variety of articles on the effects of the Covid-19 pandemic on life sciences companies, covering issues including the impact on clinical research, physician practices, and vaccine pricing, procurement, and supply. You can read a selection of our thinking below.

Subscribe to receive our latest Insights.

Subscribe